Novozymes to Buy Merck KGaA's Crop BioScience Business for $275 Million
09:58 AM | December 20, 2010 | Alex Scott
Enzymes technology firm Novozymes has agreed to buy Merck KGaA’s (Darmstadt, Germany) Crop BioScience business for $275 million. The firm’s say they expect to complete the transaction at the beginning...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.